Merro Pharmaceutical Co.,Ltd

  • 2017
    Sustained release preparations are exported to Australia and multiple ANDA products are approved in the United States.
  • 2015
    Acquisition of the Polygen pharmaceutical plant in the United States;
  • 2014
    The solid preparation workshop is certified by the US FDA;
  • 2009
    Approved by the SAIC, it was successfully declared as a national enterprise.
  • 2007
    The medical bones and ichthyosis tablets of Merro Chinese Medicine Factory were awarded the national patent certificate.
  • 2005
    In 2005, it obtained TGA international certification, and in the same year, it exported to New Zealand, which is the first batch of preparation export enterprises in China;
  • 2000
    The first batch of national GMP certification;
  • 1989
    Established China Pfizer Pharmaceutical Co., Ltd., a joint venture with Pfizer Pharmaceuticals of the United States, and is the first large-scale joint venture in China;
  • 1957
    It is the first to develop erythromycin in China and become the earliest antibiotic production base in New China;
  • 1925
    Merro Pharmaceutical was founded in 1925 by the Dalian Manchurian Health Research Institute;
0411-84795668
No. 9, Yingsheng Road, Yingchengzi Industrial Park, Ganjingzi District, Dalian
Copyright © 2000-2019 Merro Pharmaceutical Co.,Ltd
LN-ICP-11010262